Perinatal Infections Market, By Infection, By Diagnosis, By Treatment, By Route of Administration, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Perinatal Infections Market size was valued at USD 4,125.2 Million in 2023, expanding at a CAGR of 6.00% from 2024 to 2032.

Infections that can spread from the mother to the child during pregnancy, labor, or the initial few hours after delivery are known as perinatal infections. Due to the limited ability of neonates, particularly those born preterm, to verbalize their symptoms, even slight deviations from the norm should be interpreted as an indication of bacterial disease. Pregnancy is a common time to see diseases such as listeria, bacterial vaginosis (BV), group B streptococcus (GBS), dermatitis, herpes, vaginal yeast infections, and the flu.

Perinatal Infections Market- Market Dynamics

Growing Prevalence of Perinatal Infections to Propel Market Growth

The global market for perinatal infections is expanding as a result of the rising prevalence of prenatal infections globally. The mother and the infant are both seriously threatened by these infections, which highlights the need for improved prevention, diagnostic, and treatment methods. Any time throughout pregnancy or during labor and delivery, a mother's health and the health of her unborn child are at danger due to perinatal infections. Human immunodeficiency virus (HIV), hepatitis B, syphilis, group B streptococcus (GBS), and chlamydia are common illnesses that can affect infants. Serious consequences include preterm birth, low birth weight, neonatal sepsis, congenital abnormalities, and mother morbidity and death can result from these infections. Furthermore, the frequency of perinatal infections is rising due to a number of causes. Undiagnosed or untreated infections are a result of inadequate access to prenatal care and scarce healthcare resources in some areas. Routine prenatal care visits are crucial to screen for and identify perinatal infections early on.Prenatal infections can result from a number of high-risk behaviors, including drug addiction, unprotected sexual activity, and having several partners. It is essential to address these habits through prevention and education initiatives.

Perinatal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.00% over the forecast period (2024-2032)

Based on infection segmentation, the human immunodeficiency virus category was predicted to show maximum market share in the year 2023

Based on diagnosis segmentation, the maternal test category was the leading segment in 2023

Based on treatment segmentation, the antibiotics category was the leading infection in 2023

Based on route of administration segmentation, the parenteral category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Perinatal Infections Market- Segmentation Analysis:

The Global Perinatal Infections Market is segmented on the basis of Infection, Diagnosis, Treatment, Route of Administration, End User and Region.

The market is divided into three categories based on diagnosis: Maternal Test, Neonatal Test, and Others. The maternal test category dominates the market. The embryo and fetus have little to no immunity; as a result, they are immune and reliant on their mother. Many illnesses can infect the fetus after crossing the placenta. Pregnant women often undergo diagnostic testing to identify any infection since germs that cause mild illnesses in them might pose a serious risk to the developing fetus or infant.

The market is divided into the following categories based on end user: Hospitals, Homecare, Specialty Clinics, and Others. The hospitals category dominates the market and is likely to maintain its dominance during the forecast period, given that hospitals are thought to be the safest places to give birth. The National Academics reports that 98.4% of American women give birth in a hospital, which is a significant portion of the market. However, because more and more expectant mothers are choosing to give birth at home or in specialized birthing centers rather than in hospitals, homecare, and specialty clinics are also expected to see rapid expansion during the forecast period.

Perinatal Infections Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Perinatal Infections. In order to emphasize the value of early identification and treatment, the healthcare industry in the area has worked hard to increase public awareness of prenatal infections. The market for perinatal infections is growing favorably as a result of government measures in North America, which frequently include screening programs, immunization campaigns, and educational initiatives.

In addition, the Perinatal Infections market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific driven by large expenditures for medical innovation and research. Advanced diagnostic tools and treatment approaches for perinatal infections have emerged as a result of research and development conducted in the Asia Pacific. The Asia Pacific market for perinatal infections is continuing to rise as a result of the region's expanding healthcare infrastructure and growing emphasis on mother and child health.

Perinatal Infections Market- Competitive Landscape:

Key companies in the perinatal infections market such as Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, and Hologic Inc., among others, are concentrating on strategic efforts, including partnerships, mergers and acquisitions, and product innovations in order to obtain a competitive edge in a highly competitive landscape. These businesses hope to increase market share and satisfy customers' and healthcare providers' changing demands by capitalizing on diagnosis breakthroughs and diversifying their product offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERINATAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck KgaA
Beckman Coulter Inc.
BIOMERIEUX
Bio-Rad Laboratories, Inc
Danaher
Hologic Inc.
Gilead Sciences, Inc.
Emcure Pharmaceuticals Limited.
Cipla Inc.
Hetero
Bausch Health Companies Inc.
Johnson & Johnson Private Limited
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION- MARKET ANALYSIS, 2019 - 2032

Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

Maternal Test
Neonatal Test
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

Antibiotics
Antiviral
Antiretroviral
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Oral
Parenteral
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Homecare
Specialty Clinics
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV3568

1. Perinatal Infections Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Perinatal Infections Market Snippet by Infection
- 2.1.2. Perinatal Infections Market Snippet by Diagnosis
- 2.1.3. Perinatal Infections Market Snippet by Treatment
- 2.1.4. Perinatal Infections Market Snippet by Route of Administration
- 2.1.5. Perinatal Infections Market Snippet by End User
- 2.1.6. Perinatal Infections Market Snippet by Country
- 2.1.7. Perinatal Infections Market Snippet by Region
2.2. Competitive Insights

3. Perinatal Infections Key Market Trends

3.1. Perinatal Infections Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Perinatal Infections Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Perinatal Infections Market Opportunities
3.4. Perinatal Infections Market Future Trends

4. Perinatal Infections Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Perinatal Infections Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Perinatal Infections Market Landscape

6.1. Perinatal Infections Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Perinatal Infections Market - By Infection

7.1. Overview
- 7.1.1. Segment Share Analysis, By Infection, 2023 & 2032 (%)
- 7.1.2. Cytomegalovirus Infection
- 7.1.3. Enterovirus Infection
- 7.1.4. Genital Herpes
- 7.1.5. Gonorrhoea
- 7.1.6. Human Immunodeficiency Virus
- 7.1.7. Others

8. Perinatal Infections Market - By Diagnosis

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 8.1.2. Maternal Test
- 8.1.3. Neonatal Test
- 8.1.4. Others

9. Perinatal Infections Market - By Treatment

9.1. Overview
- 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 9.1.2. Antibiotics
- 9.1.3. Antiviral
- 9.1.4. Antiretroviral
- 9.1.5. Others

10. Perinatal Infections Market - By Route of Administration

10.1. Overview
- 10.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 10.1.2. Oral
- 10.1.3. Parenteral
- 10.1.4. Others

11. Perinatal Infections Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Homecare
- 11.1.4. Specialty Clinics
- 11.1.5. Others

12. Perinatal Infections Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Perinatal Infections Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Perinatal Infections Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Perinatal Infections Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Perinatal Infections Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Perinatal Infections Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Perinatal Infections Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Merck KgaA
- 13.2.2. Beckman Coulter Inc.
- 13.2.3. BIOMERIEUX
- 13.2.4. Bio-Rad Laboratories, Inc
- 13.2.5. Danaher
- 13.2.6. Hologic Inc.
- 13.2.7. Gilead Sciences, Inc.
- 13.2.8. Emcure Pharmaceuticals Limited.
- 13.2.9. Cipla Inc.
- 13.2.10. Hetero
- 13.2.11. Bausch Health Companies Inc.
- 13.2.12. Johnson & Johnson Private Limited
- 13.2.13. Mylan N.V.
- 13.2.14. Teva Pharmaceutical Industries Ltd.
- 13.2.15. Sanofi
- 13.2.16. Novartis AG
- 13.2.17. Sun Pharmaceutical Industries Ltd
- 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us